Quotient Limited (QTNT)
| Market Cap | 40.35M |
| Revenue (ttm) | 38.37M |
| Net Income (ttm) | -140.09M |
| Shares Out | 102.60M |
| EPS (ttm) | -1.34 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 363,693 |
| Open | 0.400 |
| Previous Close | 0.389 |
| Day's Range | 0.385 - 0.435 |
| 52-Week Range | 0.380 - 4.530 |
| Beta | 2.49 |
| Analysts | Buy |
| Price Target | 6.25 (+1,489.1%) |
| Earnings Date | Jun 7, 2022 |
About QTNT
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, w...
Financial Performance
In 2020, Quotient's revenue was $43.38 million, an increase of 32.84% compared to the previous year's $32.66 million. Losses were -$111.03 million, 5.61% more than in 2019.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for QTNT stock is "Buy." The 12-month stock price forecast is 6.25, which is an increase of 1,489.12% from the latest price.
News
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
JERSEY, Channel Islands, May 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the opening of its new office in Dubai, UAE, and the in...
Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator's Ci...
New York Blood Center, Inc. and Centro de Transfusiones de la Comunidad de Madrid join MosaiQ's Innovator's Circle in partnership to improve patient care and laboratory efficiencies New York Blood Cente...
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on a single multimodal multiplexing platform The Extended Immunoh...
Quotient (QTNT) Reports Q3 Loss, Tops Revenue Estimates
Quotient (QTNT) delivered earnings and revenue surprises of -76% and 10.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business Update
JERSEY, Channel Islands, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today r...
Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
JERSEY, Channel Islands, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate...
Quotient Limited Announces Equity Awards
JERSEY, Channel Islands, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to M...
Quotient Limited Provides MosaiQ Regulatory & Commercial Update
JERSEY, Channel Islands, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company headquartered in Eysins, Switzerland, today announced its attendance for...
Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
JERSEY, Channel Islands, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter en...
Quotient (QTNT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quotient Limited Launches Scientific Advisory Board and Research Programs
JERSEY, Channel Islands, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company headquartered in Eysins, Switzerland, today provided a Scientific Adviso...
Quotient (QTNT) Upgraded to Buy: Here's What You Should Know
Quotient (QTNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Rising P/E: An Overlooked Trick to Land on 5 Winning Stocks
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Quotient (QTNT) Could Find Support Soon, Here's Why You Should Buy the Stock Now
Quotient (QTNT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall St...
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
JERSEY, Channel Islands, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the company received feedback from the European notifi...
Is the Options Market Predicting a Spike in Quotient Limited (QTNT) Stock?
Investors need to pay close attention to Quotient Limited (QTNT) stock based on the movements in the options market lately.
Quotient Limited Provides Second Quarter Fiscal 2022 Results
JERSEY, Channel Islands, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today r...
Quotient Limited to Participate in the Jefferies London Healthcare Conference
JERSEY, Channel Islands, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the J...
Analysts Estimate Quotient (QTNT) to Report a Decline in Earnings: What to Look Out for
Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Princ...
JERSEY, Channel Islands, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has received unanimous consents from t...
Quotient Limited Announces Appointment of Chief Financial Officer
JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company's Chief Financial Officer (C...
Quotient Limited Announces Appointment of Chief Commercial Officer
JERSEY, Channel Islands, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Mohammad El Khoury as the Company's Chief Commercial O...
Is the Options Market Predicting a Spike in Quotient (QTNT) Stock?
Investors need to pay close attention to Quotient (QTNT) stock based on the movements in the options market lately.
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
JERSEY, Channel Islands, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Sci...
Why Shares of Quotient Limited Soared Friday
The company presented good news regarding a product's potential approval in Europe.